Pressure BioSciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Shareholders Equity

Shareholders Equity (USD $)	Series D Preferred Stock USD ($)	Series G Preferred Stock USD ($)	Series H Preferred Stock USD ($)	Series H2 Preferred Stock	Series J Preferred Stock USD ($)	Series K Preferred Stock USD ($)	Common Stock USD ($)	Warrant USD ($)	Additional Paid-In Capital USD ($)	Accumulated Deficit USD ($)	Total USD ($)
Beginning Balance - Amount at Dec. 31, 2012	$ 3	$ 1,453
Beginning Balance - Shares at Dec. 31, 2012	300	145,320
Stock-based compensation									136,796		136,796us-gaap_ShareBasedCompensation
Fair value of common stock issued for services, Shares							875,000
Fair value of common stock issued for services, Amount							8,750		467,962		476,712
Offering costs for issuance of preferred stock									(67,739)		(67,739)
Issuance of warrants in connection short-term loans								73,647			73,647
Issuance of warrants for services, Amount								21,028			21,028pbio_IssuanceOfWarrantsForServices
Beneficial conversion of issued preferred stock									1,002,602	(1,002,602)
Issuance of Series J convertible preferred stock, Shares					5,088
Issuance of Series J convertible preferred stock, Amount					51			885,309	1,149,340		2,034,700
Issuance of Series K convertible preferred stock, Shares						4,000
Issuance of Series K convertible preferred stock, Amount						40		271,422	728,538		1,000,000
Reclassification of conversion option liabilities									141,704		141,704
Conversion of common stock to preferred stock, Shares			10,000				(1,000,000)
Conversion of common stock to preferred stock, Amount			100				(10,000)		9,900
Dividends earned on preferred stock, Amount										(160,420)	(160,420)us-gaap_DividendsPreferredStockCash
Net loss										(4,084,427)	(4,084,427)us-gaap_NetIncomeLoss
Ending Balance, Amount at Dec. 31, 2013	3	1,453	100		51
Ending Balance, Shares at Dec. 31, 2013	300	145,320	10,000		5,088
Stock-based compensation									101,125		101,125us-gaap_ShareBasedCompensation
Fair value of common stock issued for services, Shares							588,830
Fair value of common stock issued for services, Amount							5,888		208,304		214,192
Offering costs for issuance of preferred stock									(8,000)		(8,000)
Issuance of warrants in connection short-term loans								49,599			49,599
Issuance of warrants for services, Shares								93,488			93,488
Issuance of stock in lieu of cash for Board of Director fees, Shares						399
Issuance of stock in lieu of cash for Board of Director fees, Amount						3		24,578	60,169		84,750
Exercise of warrants, Shares							596,658
Exercise of warrants, Amount							5,967		143,198		149,165pbio_ExerciseOfWarrantsAmount
Beneficial conversion of issued preferred stock									1,495,415	(1,495,415)
Warrant reset, Shares							3,612,000
Warrant reset, Amount							36,120	163,654	662,745		862,519pbio_WarrantResetAmount
Conversion of Series G convertible preferred stock, Shares		(58,750)					587,500
Conversion of Series G convertible preferred stock, Amount		(587)					5,875		(5,288)
Conversion of Series J convertible preferred stock, Shares					(1,542)		1,541,000
Conversion of Series J convertible preferred stock, Amount					(15)		15,410		(15,395)
Conversion of Series K convertible preferred stock, Shares						(1,099)	1,099,000
Conversion of Series K convertible preferred stock, Amount						(11)	10,990		(10,979)
Conversion of debt for common stock, Shares							510,000
Conversion of debt for common stock, Amount							5,100		131,400		136,500
Issuance of Series K convertible preferred stock, Shares						8,176
Issuance of Series K convertible preferred stock, Amount						82		654,845	1,592,432		2,247,359
Reclassification of conversion option liabilities									320,338		320,338
Conversion of common stock to preferred stock, Shares				21			(2,100,000)
Conversion of common stock to preferred stock, Amount							(21,000)		21,000
Reclassification of Series D warrant liability									330,405		330,405
Dividends earned on preferred stock, Amount										(143,771)	(143,771)us-gaap_DividendsPreferredStockCash
Issuance of common stock for preferred dividends, Shares							214,135
Issuance of common stock for preferred dividends, Amount							2,141		80,774		82,915
Net loss										(4,612,540)	(4,612,540)us-gaap_NetIncomeLoss
Ending Balance, Amount at Dec. 31, 2014	$ 3	$ 866	$ 100		$ 36	$ 114	$ 186,734	$ 5,253,566	$ 24,617,564	$ (32,118,714)	$ (2,059,731)
Ending Balance, Shares at Dec. 31, 2014	300	86,570	10,000	21	3,546	11,416	18,673,390